193 related articles for article (PubMed ID: 37945159)
21. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
22. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.
Rogers SA; Podolsky DK
Hepatology; 1994 Feb; 19(2):543-5. PubMed ID: 8294114
[No Abstract] [Full Text] [Related]
23. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease.
Deneau M; Adler DG; Schwartz JJ; Hutson W; Sorensen J; Book L; Lowichik A; Guthery S
J Pediatr Gastroenterol Nutr; 2011 May; 52(5):617-20. PubMed ID: 21502832
[No Abstract] [Full Text] [Related]
24. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
25. Primary sclerosing cholangitis: detection of cancer in strictures.
Schulick RD
J Gastrointest Surg; 2008 Mar; 12(3):420-2. PubMed ID: 17999125
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
27. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
29. Screening for malignancy in primary sclerosing cholangitis (PSC).
Khaderi SA; Sussman NL
Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
[TBL] [Abstract][Full Text] [Related]
30. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
Caldwell SH; Bickston SJ
Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302
[No Abstract] [Full Text] [Related]
31. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
de Groen PC
Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
[No Abstract] [Full Text] [Related]
32. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
[TBL] [Abstract][Full Text] [Related]
33. Cholangiocarcinoma in primary sclerosing cholangitis.
Abbas G; Lindor KD
J Gastrointest Cancer; 2009; 40(1-2):19-25. PubMed ID: 19705300
[TBL] [Abstract][Full Text] [Related]
34. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
35. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
Vedeld HM; Grimsrud MM; Andresen K; Pharo HD; von Seth E; Karlsen TH; Honne H; Paulsen V; Färkkilä MA; Bergquist A; Jeanmougin M; Aabakken L; Boberg KM; Folseraas T; Lind GE
Hepatology; 2022 Jan; 75(1):59-73. PubMed ID: 34435693
[TBL] [Abstract][Full Text] [Related]
36. Early detection and treatment of cholangiocarcinoma.
Gores GJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
38. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
Folseraas T; Boberg KM
Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
[TBL] [Abstract][Full Text] [Related]
39. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]